Cleared Traditional

PathBuilder Transseptal Needle

K212625 · Shanghai Microport EP Medtech Co., Ltd. · Cardiovascular
Mar 2022
Decision
217d
Days
Class 2
Risk

About This 510(k) Submission

K212625 is an FDA 510(k) clearance for the PathBuilder Transseptal Needle, a Trocar (Class II — Special Controls, product code DRC), submitted by Shanghai Microport EP Medtech Co., Ltd. (Shanghai, CN). The FDA issued a Cleared decision on March 23, 2022, 217 days after receiving the submission on August 18, 2021. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1390.

Submission Details

510(k) Number K212625 FDA.gov
FDA Decision Cleared SESE
Date Received August 18, 2021
Decision Date March 23, 2022
Days to Decision 217 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DRC — Trocar
Device Class Class II — Special Controls
CFR Regulation 21 CFR 870.1390

Similar Devices — DRC Trocar

All 50
Accusafe Transseptal Guidewire (GTR31180, GTR31230)
K240246 · Synaptic Medical Corporation · Jul 2024
SafeSharp Transseptal Needle (CLICK071, CLICK171, CLICK098, CLICK198)
K241042 · Pressure Products Medical Device Manufacturing, LLC · May 2024
SafeSept? Transseptal Guidewire (SS-140)
K221707 · Pressure Products Medical Device Manufacturing, LLC · Sep 2022
SafeSept Blunt Needle
K210328 · Pressure Products Medical Device Manufacturing, LLC · Mar 2021
TSN Transseptal Needle
K172950 · Pressure Products Medical Device Manufacturing, LLC · Feb 2018
Needle Free Transseptal Cannula
K172934 · Pressure Products Medical Device Manufacturing, LLC · Feb 2018